Ordenar

Buscar

26/06/2023 A new era and future of education: the impact of pandemic on online learning-a study from the European School of Urology
Rivas, JG, Belenchon, IR, Li, N, Somani, B, Esteban, EA, Cacciamani, G, Checcucci, E, Puliatti, S, Taratkin, M, Kowalewski, KF, Rodler, S, Veccia, A, Palou, J, Liatsikos, E. A new era and future of education: the impact of pandemic on online learning-a study from the European School of Urology. Central European Journal Of Urology. 2023; 76(3)DOI:10.5173/ceju.2023.059. PMID:38045782. IF:(Q/D).
26/06/2023 Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study
Santos J.R., Casadellà M., Noguera-Julian M., Micán-Rivera R., Domingo P., Antela A., Portilla J., Sanz J., Montero-Alonso M., Navarro J., Masiá M., Valcarce-Pardeiro N., Ocampo A., Pérez-Martínez L., García-Vallecillos C., Vivancos M.J., Imaz A., Iribarren J.A., Hernández-Quero J., Villar-García J., Barrufet P., Paredes R.. Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study. Frontiers in Cellular and Infection Microbiology. 2023; 13DOI:10.3389/fcimb.2023.1187999. PMID:37434782. IF:4.600(Q1/3D).
25/06/2023 Age, CD34+cell dose, conditioning and pre-transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation
Regalado-Artamendi, I, Garcia-Fasanella, M, Medina, L, Fernandez-Sojo, J, Esquirol, A, Garcia-Cadenas, I, Martino, R, Briones, J, Sierra, J, Novelli, S. Age, CD34+cell dose, conditioning and pre-transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation. VOX SANGUINIS. 2023; 118(8)DOI:10.1111/vox.13486. PMID:37356813. IF:1.800(Q3/7D).
23/06/2023 Targeting lysyl-oxidase (LOX) may facilitate intramural periarterial drainage for the treatment of Alzheimer's disease
Kelly L., Sharp M.M., Thomas I., Brown C., Schrag M., Antunes L.V., Solopova E., Martinez-Gonzalez J., Rodríguez C., Carare R.O.. Targeting lysyl-oxidase (LOX) may facilitate intramural periarterial drainage for the treatment of Alzheimer's disease. Cerebral Circulation - Cognition And Behavior. 2023; 5DOI:10.1016/j.cccb.2023.100171. PMID:37457664. IF:(Q/D).
22/06/2023 Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci
Escrihuela-Vidal, F, Berbel, D, Fernández-Hidalgo, N, Escola-Vergé, L, Muñoz, P, Olmedo, M, Goenaga, MA, Goikoetxea, J, Fariñas, MC, De Alarcón, A, Miró, JM, Ojeda, G, Plata, A, Cuervo, G, Carratalà, J. Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci. CLINICAL INFECTIOUS DISEASES. 2023; 77(9)DOI:10.1093/cid/ciad375. PMID:37345869. IF:8.200(Q1/1D).
21/06/2023 Late-Onset Beta-Propeller Protein-Associated Neurodegeneration: A Case Report
Collet-Vidiella, R, Olmedo-Saura, G, Ruiz-Barrio, I, Martinez-Viguera, A, Rodriguez-Santiago, B, Bernal, S, Kulisevsky, J, Pagonabarraga, J. Late-Onset Beta-Propeller Protein-Associated Neurodegeneration: A Case Report. Movement Disorders Clinical Practice. 2023; 10(8)DOI:10.1002/mdc3.13811. PMID:37635772. IF:2.600(Q2/5D).
21/06/2023 Dermoscopic features of trichoepithelioma: A multicentre observational case-control study conducted by the International Dermoscopy Society
Longo C., Lippolis N., Lai M., Spadafora M., Kaleci S., Condorelli A.G., Lombardi M., Pampena R., Argenziano G., Nazzaro G., Scalvenzi M., Akay B.N., Broganelli P., Fargnoli M.C., Paoli J., Yélamos O., Pellacani G., Borsari S., Lallas A.. Dermoscopic features of trichoepithelioma: A multicentre observational case-control study conducted by the International Dermoscopy Society. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(10)DOI:10.1111/jdv.19262. PMID:37326166. IF:8.500(Q1/1D).
21/06/2023 Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction
Esteban-Fernandez, A, Gomez-Otero, I, Lopez-Fernandez, S, Santamarta, MR, Pastor-Perez, FJ, Fluvia-Brugues, P, Perez-Rivera, JA, Lopez, AL, Garcia-Pinilla, JM, Palomas, JLB, Bonet, LA, Cobo-Marcos, M, Mateo, VM, Llergo, JT, Fernandez, VA, Vives, CG, Baguda, JD, Benedicto, AM, de Polavieja, JIM, Solla-Ruiz, I, Sole-Gonzalez, E, Cardona, M, Olaetxea, JR, Cortes, CO, Dosantos, VM, Lopez, AG, Amao, E, Sanchez, BC, Torres, EA, Carrillo, VG, Garcia-Fuertes, D, Ridocci-Soriano, F. Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction. Clinical Research in Cardiology. 2023; DOI:10.1007/s00392-023-02241-0. PMID:37341769. IF:3.800(Q1/3D).